Alternate data sets shed light where darkened CDC couldn't: Cases continue to rise
First up: ACA, CHIP, drug prices
Still in play: Individual mandate, trusted exchange, the ONC reorg, meaningful use, CHIP and more
Healthcare exec Paul Levy is not optimistic about value-based care. To put it mildly.
The 2018 rule drop was well-received. But it might be too good to be true.
Primary care practices leave revenue on the table as ACP, CCM codes are underutilized
Are new tweaks to payment programs revolutionary, or just a rebrand?
3 things to know about the latest ACA repeal attempt
Paul F. Levy on how other countries handle national insurance — and private supplements